{"count": 3, "results": [{"_id": "32129462", "pmid": 32129462, "title": "Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis.", "journal": "J Gerontol A Biol Sci Med Sci", "authors": ["Ahmadi S", "Razazan A", "Nagpal R", "Jain S", "Wang B", "Mishra SP", "Wang S", "Justice J", "Ding J", "McClain DA", "Kritchevsky SB", "Kitzman D", "Yadav H"], "date": "2020-06-18T00:00:00Z", "doi": "10.1093/gerona/glaa056", "meta_date_publication": "2020 Jun 18", "meta_volume": "75", "meta_issue": "7", "meta_pages": "e9-e21", "score": 50281.355, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Reduces Aging-Related Leaky @<m>DISEASE_Winter_Shortland_Temple_syndrome</m> @DISEASE_MESH:C536735 @@@Gut@@@ and Improves Cognitive @DISEASE_Conversion_Disorder @DISEASE_MESH:D003291 @@@Function@@@ by Beneficially Modulating @<m>DISEASE_Winter_Shortland_Temple_syndrome</m> @DISEASE_MESH:C536735 @@@Gut@@@ Microbiome/Goblet Cell/Mucin Axis.", "citations": {"NLM": "Ahmadi S, Razazan A, Nagpal R, Jain S, Wang B, Mishra SP, Wang S, Justice J, Ding J, McClain DA, Kritchevsky SB, Kitzman D, Yadav H. Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis. J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):e9-e21. PMID: 32129462", "BibTeX": "@article{32129462, title={Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis.}, author={Ahmadi S and Razazan A and Nagpal R and Jain S and Wang B and Mishra SP and Wang S and Justice J and Ding J and McClain DA and Kritchevsky SB and Kitzman D and Yadav H}, journal={J Gerontol A Biol Sci Med Sci}, volume={75}, number={7}, pages={e9-e21}}"}}, {"_id": "33662832", "pmid": 33662832, "pmcid": "PMC7930590", "title": "LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy", "journal": "EBioMedicine", "authors": ["Planas D", "Pagliuzza A", "Ponte R", "Fert A", "Marchand LR", "Massanella M", "Gosselin A", "Mehraj V", "Dupuy FP", "Isnard S", "Goulet JP", "Lesage S", "Cohen EA", "Ghali MP", "Angel JB", "Chomont N", "Routy JP", "Ancuta P"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.ebiom.2021.103270", "meta_date_publication": "2021 Mar", "meta_volume": "65", "meta_issue": "", "meta_pages": "103270", "score": 50249.137, "text_hl": "@GENE_CD4 @GENE_920 @@@CD4@@@+ T-cell counts, @GENE_CD4 @GENE_920 @@@CD4@@@+/@GENE_CD8A @GENE_925 @@@CD8@@@+ T-cell ratios, plasma markers of @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@/@<m>DISEASE_Winter_Shortland_Temple_syndrome</m> @DISEASE_MESH:C536735 @@@gut damage@@@, as well as levels of cell-associated integrated @SPECIES_11676 @@@HIV@@@-DNA and @SPECIES_11676 @@@HIV@@@-RNA, and transcriptionally-inducible @SPECIES_11676 @@@HIV@@@ reservoirs, underwent minor variations in the blood in response to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Planas D, Pagliuzza A, Ponte R, Fert A, Marchand LR, Massanella M, Gosselin A, Mehraj V, Dupuy FP, Isnard S, Goulet JP, Lesage S, Cohen EA, Ghali MP, Angel JB, Chomont N, Routy JP, Ancuta P. LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy EBioMedicine. 2021 Mar;65():103270. PMID: 33662832", "BibTeX": "@article{33662832, title={LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy}, author={Planas D and Pagliuzza A and Ponte R and Fert A and Marchand LR and Massanella M and Gosselin A and Mehraj V and Dupuy FP and Isnard S and Goulet JP and Lesage S and Cohen EA and Ghali MP and Angel JB and Chomont N and Routy JP and Ancuta P}, journal={EBioMedicine}, volume={65}, pages={103270}}"}}, {"_id": "29350661", "pmid": 29350661, "pmcid": "PMC6166165", "title": "Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia", "journal": "Acta Biomed", "authors": ["Di Pierro F", "Putignano P", "Villanova N"], "date": "2018-01-16T00:00:00Z", "doi": "10.23750/abm.v88i4.5851", "meta_date_publication": "2018 Jan 16", "meta_volume": "88", "meta_issue": "4", "meta_pages": "462-469", "score": 50041.656, "text_hl": "Consequently, @CHEMICAL_Berberine @CHEMICAL_MESH:D001599 @@@berberine@@@-based therapies are suggested by physicians for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Irritable_Bowel_Syndrome @DISEASE_MESH:D043183 @@@IBS@@@ or @<m>DISEASE_Winter_Shortland_Temple_syndrome</m> @DISEASE_MESH:C536735 @@@gut@@@ discomfort caused by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Di Pierro F, Putignano P, Villanova N. Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia Acta Biomed. 2018 Jan 16;88(4):462-469. PMID: 29350661", "BibTeX": "@article{29350661, title={Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia}, author={Di Pierro F and Putignano P and Villanova N}, journal={Acta Biomed}, volume={88}, number={4}, pages={462-469}}"}}]}